PharmaAccess
PharmaAccess is a Dubai-based private pharmaceutical company founded in 2008 that markets, sells, and distributes pharmaceutical brands across 51-100 employees, serving regional pharmaceutical markets from its UAE headquarters.
- Company typePrivate
- Founded2008
- HeadquartersDubai, United Arab Emirates
- Headcount51–100
- GTM typeB2B
- OfferingServices
What PharmaAccess does
PharmaAccess is a Dubai-based private pharmaceutical company founded in 2008 that operates as a marketer, seller, and distributor of pharmaceutical brands. The firm runs as a for-profit entity with 51-100 employees and is headquartered in the United Arab Emirates — a recognized regional hub for pharmaceutical trade and re-export into the Middle East and Africa. Its commercial scope spans the full downstream pharma value chain: brand commercialization (marketing), commercial sales, and physical distribution of pharmaceutical products. The specific therapeutic categories, brand portfolio composition, customer segments (manufacturer principals, pharmacy chains, hospitals, government buyers), and channel mix (retail pharmacy, hospital supply, institutional tender, OTC) are not disclosed in the available source material.
The company's revenue model and go-to-market mechanics are not directly documented. As a distributor-marketer, the implied business model combines distribution margins on physical product movement with potential commercial service fees (marketing, sales representation, or in-licensing of brand rights). Pricing models, contract structures, customer concentration, and supplier relationships are all absent from the captured data, and the firm's own website (pharmaaccess.com) returned only a verification/loading page during capture, providing no substantive corporate content. There is no disclosed parent company, subsidiary structure, ownership commentary, management team, or board composition.
Material data gaps prevent a more granular assessment: there are no recorded funding rounds, no M&A activity, no leadership changes, no product launches, no partnerships, no certifications or regulatory approvals, no patents or trademarks, no office locations beyond Dubai, no social media profiles, and no customer references. For an investment-grade evaluation, primary research — direct management outreach, financial disclosures (where available under UAE commercial law), customer/supplier reference checks, and registry-based ownership lookups — would be required to substantiate any directional thesis.
PharmaAccess firmographics
Firmographics- Name
- PharmaAccess
- Website
- https://pharmaaccess.com
- Company type
- Private
- Founded year
- 2008
- Headcount range
- 51–100 employees
- Short description
- PharmaAccess is a Dubai-based private pharmaceutical company founded in 2008 that markets, sells, and distributes pharmaceutical brands across 51-100 employees, serving regional pharmaceutical markets from its UAE headquarters.
- Ownership category
- akta.pro rank
PharmaAccess industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)
- akta.pro secondary industry
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
Keywords
Where PharmaAccess is headquartered
LocationHeadquarters
- HQ city
- Dubai
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Markets served
PharmaAccess business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Marketing or Sales, Personnel, Operations
PharmaAccess product offering
Product offeringCore offering
PharmaAccess is a marketer, seller, and distributor of pharmaceutical brands, operating in Dubai, United Arab Emirates. The company was founded in 2008 and works with pharmaceutical brands to commercialize and distribute them across markets. Specific product-level details are not available in the provided source data.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Brand Marketing and Distribution Services
Companies that use PharmaAccess
Customer profileIdeal customer profiles2 records
PharmaAccess technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
PharmaAccess partnerships and signals
Strategic signalExpansion highlights1 record
PharmaAccess competitors and assessment
Company assessmentDirect peers
- Global Pharma Healthcare: UAE-based distributor of branded pharmaceuticals and consumer health products; comparable as a regional mid-market pharma distribution and marketing partner.
- Life Pharma: UAE pharmaceutical distribution and marketing company focused on branded and specialty products; similar operating model and customer base (regional pharmacies and institutional buyers).
- Modern Pharmaceutical Company (MPC): UAE-headquartered pharma distributor and marketing firm representing international brand owners in MENA; matches PharmaAccess on the integrated marketing-sales-distribution model for branded products.
- Al Ittihad Drug Store: UAE-based pharmaceutical distributor and marketing company handling branded pharma principals across the Gulf; directly comparable in business model (sell/distribute/market) and regional footprint to PharmaAccess.
- Medpharma (UAE): UAE pharma distributor representing multinational brand owners; comparable in the sell-distribute-market value chain serving the GCC market.
Regional players
- Tabuk Pharmaceuticals: Saudi-headquartered branded pharma manufacturer expanding into distribution across MENA; overlaps with PharmaAccess in regional branded pharma commercialization.
Broad incumbents
- Julphar (Gulf Pharmaceutical Industries): Largest UAE-based pharmaceutical manufacturer with significant in-house distribution; competes for branded pharma shelf space and principal relationships, making it an incumbent benchmark rather than a pure peer.
- Hikma Pharmaceuticals: MENA-origin branded and generic pharma manufacturer with its own regional sales/distribution; competes for the same brand-principal mandates and end-customer relationships across MENA.
- SPIMACO Addwaeih: Saudi pharmaceutical manufacturer and distributor with GCC-wide commercialization capability; serves as a regional incumbent benchmark for branded pharma distribution scale.
- Cipla (MENA operations): Indian multinational with established MENA sales/marketing/distribution footprint; competes for branded and generic distribution contracts and partner-brand mandates in the same geography.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
PharmaAccess social profiles
Digital presencePharmaAccess financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaAccess leadership team
Management profileNumber of profiles
PharmaAccess funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaAccess M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaAccess
What does PharmaAccess do?
PharmaAccess is a marketer, seller, and distributor of pharmaceutical brands, operating in Dubai, United Arab Emirates. The company was founded in 2008 and works with pharmaceutical brands to commercialize and distribute them across markets. Specific product-level details are not available in the provided source data.
When was PharmaAccess founded?
PharmaAccess was founded in 2008. It employs 51 to 100 people.
Where is PharmaAccess based?
PharmaAccess is headquartered in Dubai, United Arab Emirates, in the Middle East region.
Who are PharmaAccess's main competitors?
Direct peers on record are Global Pharma Healthcare, Life Pharma, Modern Pharmaceutical Company (MPC), Al Ittihad Drug Store and Medpharma (UAE). Tabuk Pharmaceuticals is listed as a regional player. Broad incumbents are Julphar (Gulf Pharmaceutical Industries), Hikma Pharmaceuticals, SPIMACO Addwaeih and Cipla (MENA operations).
Does PharmaAccess have an API?
No public API is recorded for PharmaAccess.
What industry is PharmaAccess in?
PharmaAccess's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is CRAOAHAK, Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops), with a secondary code of HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply). Its NAICS code is 424210 and its SIC code is 5122.